Video

Comparing Cancer Rates for Hepatitis C Patients to Those with No Cancer

Author(s):

There are medications which can all but cure hepatitis C but for those patients who have not yet beaten the condition there is research that shows a link to developing cancer.

There are medications which can all but cure hepatitis C but for those patients who have not yet beaten the condition there is research that shows a link to developing cancer.

Anders Nyberg, MD, from Kaiser Permanente Medical Center discussed this health concern during Digestive Disease Week in Washington, DC. Nyberg said one of the biggest surprises in the research presented is how prevalent liver cancer was in these patients. He noted the rate was almost 70 times more for these patients proving how important it is to prevent cirrhosis before it becomes an even greater problem.

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.